KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to -$155.0 million.

  • Bristol Myers Squibb's Change in Receivables rose 7655.07% to -$155.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $171.0 million, marking a year-over-year decrease of 5581.4%. This contributed to the annual value of -$264.0 million for FY2024, which is 12653.27% down from last year.
  • Per Bristol Myers Squibb's latest filing, its Change in Receivables stood at -$155.0 million for Q3 2025, which was up 7655.07% from $484.0 million recorded in Q2 2025.
  • Bristol Myers Squibb's Change in Receivables' 5-year high stood at $1.0 billion during Q2 2024, with a 5-year trough of -$786.0 million in Q1 2022.
  • In the last 5 years, Bristol Myers Squibb's Change in Receivables had a median value of $168.0 million in 2021 and averaged $145.4 million.
  • In the last 5 years, Bristol Myers Squibb's Change in Receivables plummeted by 107313.43% in 2022 and then surged by 146769.23% in 2024.
  • Over the past 5 years, Bristol Myers Squibb's Change in Receivables (Quarter) stood at $168.0 million in 2021, then tumbled by 36.9% to $106.0 million in 2022, then surged by 379.25% to $508.0 million in 2023, then plummeted by 128.15% to -$143.0 million in 2024, then fell by 8.39% to -$155.0 million in 2025.
  • Its Change in Receivables stands at -$155.0 million for Q3 2025, versus $484.0 million for Q2 2025 and -$15.0 million for Q1 2025.